their mfg costs are a direct expense since they do not have
their mfg costs are a direct expense since they do not have any plant or equipment to deal with. all contract costs so rather easy to account for. Veal has given updates to laid in cost per bottle and they have been in past 10Qs/10Ks. they continue to decrease and will continue to do so as the volume increases until they flatten out at max production volume discount.
SG&A is relatively small as they do not have many on the direct payroll (Veal, Adamson, a couple of sales people, and maybe admin?) and the rest of sales/marketing is handled through SMS. much of the salary from the insiders has been deferred per past filings. that will obviously increase as cash flow strengthens. they also do very little in terms of general advertisement and have resorted to giveaways, festivals, small vendor shows, etc and co-oping vendor space with partners when applicable to keep costs down (Vegas shows where they had the dual booth). they have been pretty saavy at getting press through BevNet, social media, TV shows, LTCG SM network, etc to help further the brand at a low cost.
licensing fees are with LTCG as i think they ended the agreement with WB for the Hangover Movie /characters.
i would not expect a profit as all of the net margin would probably be funneled back into advertising/marketing, short term debt payoff (still have convertible debt to close out), and future production runs where terms are extended (unlike foreign terms where half is paid up front which is where the foreign deals are very lucrative starting out - dramatically helps cash flow).
when they do start showing net income - they have significant accrued losses to offset future gains and eliminate income tax (40% on net income) for probably several years which will also help cash flow.
as others have stated - net income is not a driver right now. while profitable growth is crucial long term for any business - right now revenues and brand building are critical. at their target laid in costs (approaching $0.20/bottle) and selling anywhere from probably $0.90-1.40 based on volume - that still allows significant margins to drive significant profitability.
3
Hangover Joe's Holding Corporation (HJOE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
No one just stumbles into 400 successful deals without a whole lot of grit, especially in the gnarly jungle of health care services mergers and acquisitions. The Braff Group, a stalwart in this arena since 1998, has just hit this remarkable milestone. If you ask me, this isn't just a number—it's a testament to the blood, sweat, and relentless dedication poured into...
Continue Reading
Big Wins for Guaranteed Income Programs Boy, isn't it fascinating watching the political gears turn to embrace concepts like guaranteed income? This wave of enthusiasm isn't just words and ideas; it's now showing up in election results and ballot measures in multiple states. From California to Pennsylvania, voters appear to dig the idea of direct cash assistance to those...
Continue Reading
Another Big Win in Phoenix's Industrial Space Who'd have thought? Dircks Moving & Logistics just bagged themselves a hefty 337,897-square-foot lease in Phoenix. This isn’t just any warehouse deal in the Southwest Valley—it’s a mark of where the industrial real estate world’s trending these days. For those who watch these things, they’ve pushed their local space...
Continue Reading
A Partial Win for Orthopaedic Care Access This week, we’ve got a sigh of relief rolling through the orthopaedic corridors with the Centers for Medicare & Medicaid Services (CMS) dialing back on its proposed fee cuts. You’d think they were about to pull the rug out from beneath procedures most patients can't afford to get scarce. It’s not a full victory, but...
Continue Reading
Veterans Find Their Business Groove in U.S. Cities Around the diner's counter, traders might be swapping tales of market victories or lamenting lost opportunities. But today, we're chewing over a different kind of success story—the top U.S. cities paving the way for veteran entrepreneurs, courtesy of a fresh report from the PenFed Foundation for Military Heroes. This...
Continue Reading
What's the Deal with Generations+ at P.C. Richard & Son? Felt like companies were giving away the farm just to keep customers hooked, and then I heard about P.C. Richard & Son's latest play. They've been around for a scorching 117 years, and now they're offering something they've never done before: a free membership program called Generations+ that tosses perks like candy...
Continue Reading
New Glimmers of Hope in B-cell NHL Battle Battling aggressive B-cell non-Hodgkin lymphoma (B-NHL) isn't for the faint of heart, especially when standard treatments have been run through like an old pair of boots. Enter dapolsertib, the fresh-faced newcomer in Menarini Group and Ryvu Therapeutics' arsenal, showing encouraging signals in early Phase II results. These...
Continue Reading
HSBC's Strategic Capital Maneuver Alright, let's chew on this one: HSBC's out to repurchase up to a cool billion bucks worth of its own security paper. We're talking about the $3 billion, 6% Perpetual Subordinated Contingent Convertible Securities, which can be called up as soon as May 2027. Now, they're not going all-in—the offer is capped at $1 billion, though the...
Continue Reading
Inside the Baanx Data Breach: A Wake-Up Call The digital currency frontier is fraught with pitfalls, and the latest Baanx data breach saga is a sobering reminder. This isn't just a minor fumble—this one's a big, hairy mess involving sensitive data of Crypto Life users, causing ripples through an already jittery market. What Went Wrong with Baanx We're staring at...
Continue Reading
Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...
Continue Reading
Top 5 Most Recently Viewed Articles
Investors Affected by Dow Inc.'s Stock Performance Recently, Dow Inc. has encountered significant challenges affecting its stock performance, raising concerns among investors. Those who acquired shares of Dow Inc. (NYSE: DOW) are now presented with an opportunity to lead a shareholder class action lawsuit. This legal action concerns claims against Dow and its executives...
Continue Reading
A Meaningful Milestone in Northwest Bank's Journey Not every day you hear about a regional player like Northwest Bank cutting through the noise to land on TIME's list of America’s Best Companies. Clocking in at #394 out of 1,000, they seem to be doing something right among the jackals of Wall Street. Folks, they didn't just get there on blind luck—Northwest clawed its...
Continue Reading
Ameren Corporation Unveils New Stock Offering In a strategic move to bolster its financial position, Ameren Corporation (NYSE: AEE) has announced the pricing of a significant underwritten offering of common stock. The company is set to offer 5,550,416 shares at an attractive public price of $94.00 each. This offering is aimed at facilitating various corporate financial...
Continue Reading
Current Market Sentiment on Nike Nike (NKE) has recently seen an increase in its short interest, with a reported 23.96% rise since the last assessment. Currently, there are 44.81 million shares sold short, constituting 4.76% of the company’s total available shares for trading. In the context of trading volume, it is estimated that it would take approximately 1.55 days...
Continue Reading
Investigation into OSI Systems, Inc. by Pomerantz LLP Pomerantz LLP has launched a thorough investigation into the practices of OSI Systems, Inc. (NASDAQ: OSIS) following concerning claims made by investors. The firm is dedicated to uncovering the truth about potential securities violations that may have impacted the company's stakeholders. Allegations of Fraud and...
Continue Reading
